Last updated on June 2019

Efficacy and Safety of Oral Testosterone Undecanoate in Hypogonadal Men

Brief description of study

This will be a randomized, multicenter, open-label, active-controlled, efficacy, and safety study in adult hypogonadal men. The study duration is 12 months (365 days), including a 90-day, open-label efficacy period and a 9-month (275-day) safety evaluation period.

Clinical Study Identifier: NCT03198728

Find a site near you

Start Over

National Clinical Research, Inc.

Richmond, VA United States
  Connect »